Statin use in spontaneous intracerebral hemorrhage: A systematic review and meta-analysis

International Journal of Stroke

Volumn 10, Issue A100, 2015, Pages 10-17

  Jung, Jin Man ^a   Choi, Jeong Yoon ^a   Kim, Hyun Jung ^b   Seo, Woo Keun ^c  

^a Korea University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Intracerebral hemorrhage; Outcome; Statins (3 hydroxy 3 methyl glutaryl CoA reductase inhibitors)

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BRAIN HEMORRHAGE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; META ANALYSIS; MORTALITY; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; BIBLIOGRAPHIC DATABASE; CEREBRAL HEMORRHAGE; STATISTICS AND NUMERICAL DATA;

CEREBRAL HEMORRHAGE; DATABASES, BIBLIOGRAPHIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 84946499345     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12624     Document Type: Review

References (35)

1. Taylor F, Huffman MD, Macedo AF etal. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013; 1:CD004816.
2. Cimino M, Gelosa P, Gianella A, Nobili E, Tremoli E, Sironi L. Statins: multiple mechanisms of action in the ischemic brain. Neuroscientist 2007; 13:208-213.
3. Ní Chróinín D, Callaly EL, Duggan J etal. Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the North Dublin Population Stroke Study. Stroke 2011; 42:1021-1029.
4. Blanco M, Nombela F, Castellanos M etal. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 2007; 69:904-910.
5. Goldstein LB. Statin therapy should be discontinued in patients with intracerebral hemorrhage. Stroke 2013; 44:2058-2059.
6. Naval NS, Abdelhak TA, Zeballos P, Urrunaga N, Mirski MA, Carhuapoma JR. Prior statin use reduces mortality in intracerebral hemorrhage. Neurocrit Care 2008; 8:6-12.
7. FitzMaurice E, Wendell L, Snider R etal. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke 2008; 39:2151-2154.
8. Eichel R, Khoury ST, Ben-Hur T, Keidar M, Paniri R, Leker RR. Prior use of statins and outcome in patients with intracerebral haemorrhage. Eur J Neurol 2010; 17:78-83.
9. Biffi A, Devan WJ, Anderson CD etal. Statin use and outcome after intracerebral hemorrhage: case-control study and meta-analysis. Neurology 2011; 76:1581-1588.
10. George MG, Tong X. Statin use among patients with intracerebral hemorrhage in the Paul Coverdell National Acute Stroke Registry [Abstract]. Stroke 2013; 44;ATP 378.
11. Mustanoja S, Strbian D, Putaala J etal. Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage. Stroke 2013; 44:2330-2332.
12. Romero FR, Bertolini Ede F, Veloso VN, Venturini L, Figueiredo EG. Outcomes from intracerebral hemorrhage among patients pre-treated with statins. Arq Neuropsiquiatr 2011; 69:452-454.
13. King NK, Tay VK, Allen JC, Ang BT. Prior statin use has no effect on survival after intracerebral hemorrhage in a multiethnic Asian patient cohort. Acta Neurochir Suppl 2012; 114:343-346.
14. Goldstein LB, Amarenco P, Zivin J etal. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2009; 40:3526-3531.
15. Naval N. Simvastatin for intracerebral hemorrhage study (ClinicalTrials.gov Identifier: NCT00718328). 2008. Available at https://clinicaltrials.gov/ct2/show/NCT00718328.
16. Lei C, Wu B, Liu M, Chen Y. Association between statin use and intracerebral hemorrhage: a systematic review and meta-analysis. Eur J Neurol 2014; 21:192-198.
17. Tapia-Perez H, Sanchez-Aguilar M, Torres-Corzo JG etal. Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study. Cent Eur Neurosurg 2009; 70:15-20.
18. Tapia-Perez JH, Rupa R, Zilke R, Gehring S, Voellger B, Schneider T. Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage. Neurosurg Rev 2013; 36:279-287.
19. Niewada M, Skowrońska M, Sarzyńska-Długosz IM, Kamiński B, Kobayashi A, Członkowska A. Pharmacotherapy prior to and in acute haemorrhagic stroke. The use of pharmacotherapy and drugs-associated outcomes in real-world practice - findings from the Polish Hospital Stroke Registry. Neurol Neurochir Pol 2013; 47:517-524.
20. Pan YS, Jing J, Wang YL etal. Use of statin during hospitalization improves the outcome after intracerebral hemorrhage. CNS Neurosci Ther 2014; 20:548-555.
21. Flint AC, Conell C, Rao VA etal. Effect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge disposition. JAMA Neurol 2014; 71:1364-1371.
22. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available at http://handbook.cochrane.org/.
23. Morris JA, Gardner MJ. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. BMJ 1988; 296:1313-1316.
24. Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med 2013; 158:280-286.
25. Leker RR, Khoury ST, Rafaeli G, Shwartz R, Eichel R, Tanne D. Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke 2009; 40:2581-2584.
26. Dowlatshahi D, Demchuk AM, Fang J, Kapral MK, Sharma M, Smith EE. Association of statins and statin discontinuation with poor outcome and survival after intracerebral hemorrhage. Stroke 2012; 43:1518-1523.
27. Gomis M, Ois A, Rodriguez-Campello A etal. Outcome of intracerebral haemorrhage patients pre-treated with statins. Eur J Neurol 2010; 17:443-448.
28. Flaster M, Morales-Vidal S, Schneck MJ, Biller J. Statins in hemorrhagic stroke. Expert Rev Neurother 2011; 11:1141-1149.
29. Naval NS, Abdelhak TA, Urrunaga N, Zeballos P, Mirski MA, Carhuapoma JR. An association of prior statin use with decreased perihematomal edema. Neurocrit Care 2008; 8:13-18.
30. Yokoyama S, Ikeda H, Haramaki N, Yasukawa H, Katoh A, Imaizumi T. HMG-CoA reductase inhibitor protects against in vivo arterial thrombosis by augmenting platelet-derived nitric oxide release in rats. J Cardiovasc Pharmacol 2005; 45:375-381.
31. Asahi M, Huang Z, Thomas S etal. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab 2005; 25:722-729.
32. Ricard G, Garant MP, Carrier N, Leblanc N, Boulanger JM. Statins may increase intracerebral hemorrhage volume. Can J Neurol Sci 2010; 37:791-796.
33. Falcone GJ, Biffi A, Brouwers HB etal. Determinants of hematoma volume differ by location in intracerebral hemorrhage [Abstract]. Stroke 2013; 44(Suppl. 1):WP306.
34. Karki K, Knight RA, Han Y etal. Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. Stroke 2009; 40:3384-3389.
35. Jung KH, Chu K, Jeong SW etal. HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 2004; 35:1744-1749.